View Post Efficacy of an Individualized Adherence Support Program with Contingent Reinforcement among Nonadherent HIV-Positive Patients: Results from a Randomized Trial. Journal of the International Association of Physicians in AIDS Care, 5(4): 143-150. In by AHFDecember 1, 2006
View Post Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial. Clinical Infectious Diseases, 43(10): 1337-1346. In by AHFNovember 1, 2006
View Post Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients. Journal of Acquired Immune Deficiency Syndromes, 43(1): 1-5. In by AHFSeptember 1, 2006
View Post The Safety and Efficacy of Dose-Sparing Intradermal Administration of Influenza Vaccine in Human Immunodeficiency Virus–Positive Patients. Archives of Internal Medicine, (166)13: 1417. In by AHFJuly 16, 2006
View Post The Safety and Efficacy of Dose-Sparing Intradermal Administration of Influenza Vaccine in Human Immunodeficiency Virus–Positive Patients. Archives of Internal Medicine, (166)13: 1417. In by AHFJuly 1, 2006
View Post Response to: Lack of Interaction Between Atazanavir and Proton Pump Inhibitors in HIV-Infected Patients Treated with Ritonavir-Boosted Atazanavir. Journal of Acquired Immune Deficiency Syndromes, 41(3): 394. In by AHFMarch 1, 2006
View Post Interaction Between Atazanavir and Fosamprenavir in the Treatment of HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes, 41(1): 124-125. In by AHFJanuary 1, 2006
